Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 10125128 GLS1 inhibitors for treating disease

OverviewStructured DataIssuesContributorsActivity
Is a
Patent
Patent
Date Filed
June 30, 2016
Date of Patent
November 13, 2018
Patent Application Number
15199100
Patent Citations Received
‌
US Patent 11958849 GLS1 inhibitors for treating disease
0
‌
US Patent 11713313 GLS1 inhibitors for treating disease
0
‌
US Patent 11786500 Glutaminase inhibitor therapy
‌
US Patent 11370786 GLS1 inhibitors for treating disease
‌
US Patent 10344025 GLS1 inhibitors for treating disease
‌
US Patent 10722487 Glutaminase inhibitor therapy
‌
US Patent 10738043 GLS1 inhibitors for treating disease
‌
US Patent 10766892 GLS1 inhibitors for treating disease
‌
US Patent 10899740 Salt forms and polymorphs of (R)-1-(4-(6-(2-(4-(3,3-difluorocyclobutoxy)-6-methylpyridin-2-yl)acetamido)pyridazin-3-yl)-2-fluorobutyl)-N-methyl-1H-1,2,3-triazole-4-carboxamide
‌
US Patent 11045443 Glutaminase inhibitor therapy
•••
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
Patent Number
10125128
Patent Primary Examiner
‌
Jeffrey S Lundgren

Find more entities like US Patent 10125128 GLS1 inhibitors for treating disease

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo